(Q43036185)

English

Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy.

scientific article published in June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Hiromitsu Kumada

13

object named as

Hiromitsu Kumada

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Fumitaka Suzuki

2

object named as

Fumitaka Suzuki

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

12

object named as

Kenji Ikeda

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Masahiro Kobayashi

8

object named as

Masahiro Kobayashi

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Yoshiyuki Suzuki

6

object named as

Yoshiyuki Suzuki

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1

object named as

Norio Akuta

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

11

object named as

Yasuji Arase

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

5

object named as

Hitomi Sezaki

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

10

object named as

Satoshi Saitoh

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Yusuke Kawamura

4

object named as

Yusuke Kawamura

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Mariko Kobayashi

9

object named as

Mariko Kobayashi

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Miharu Hirakawa

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 June 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Journal of Medical Virology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

83

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1016-1022

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholest

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Genotypic subtyping of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Hepatocarcinogenesis following HCV RNA eradication by interferon in chronic hepatitis patients.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Characteristic mutations in hepatitis C virus core gene related to the occurrence of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Recurrence rate and prognosis of patients with hepatocellular carcinoma that developed after elimination of hepatitis C virus RNA by interferon therapy. A closed cohort study including matched control patients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Telaprevir for previously treated chronic HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Critical role of PA28 in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Why is the interferon sensitivity-determining region (ISDR) system useful in Japan?

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Identification of Hepatitis C Virus (HCV) Subtype 1b Strains That Are Highly, or Only Weakly, Associated with Hepatocellular Carcinoma on the Basis of the Secondary Structure of an Amino-Terminal Portion of the HCV NS3 Protein

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22094

21 January 2018

Identifiers

10.1002/JMV.22094

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

release_r626w2sugvaijbrxpc77cog26e

1 reference

https://api.fatcat.wiki/v0/release/r626w2sugvaijbrxpc77cog26e

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503914%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43036185&oldid=1842553070"